Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$56.27 - $73.77 $2,813 - $3,688
50 New
50 $3,000
Q2 2023

Aug 07, 2023

SELL
$62.68 - $95.05 $5,014 - $7,604
-80 Reduced 88.89%
10 $0
Q4 2022

Feb 09, 2023

SELL
$30.35 - $53.15 $546 - $956
-18 Reduced 16.67%
90 $4,000
Q3 2022

Nov 02, 2022

BUY
$31.97 - $49.37 $575 - $888
18 Added 20.0%
108 $4,000
Q1 2021

May 13, 2021

SELL
$116.57 - $155.01 $46,628 - $62,004
-400 Reduced 81.63%
90 $12,000
Q4 2020

Feb 09, 2021

BUY
$99.61 - $142.12 $39,844 - $56,848
400 Added 444.44%
490 $65,000
Q4 2019

Feb 14, 2020

BUY
$77.66 - $99.74 $6,989 - $8,976
90 New
90 $8,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.27B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Plante Moran Financial Advisors, LLC Portfolio

Follow Plante Moran Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.